These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35364254)

  • 1. Distribution of a highly lipophilic drug cannabidiol into different lymph nodes following oral administration in lipidic vehicle.
    Jewell A; Brookes A; Feng W; Ashford M; Gellert P; Butler J; Fischer PM; Scurr DJ; Stocks MJ; Gershkovich P
    Eur J Pharm Biopharm; 2022 May; 174():29-34. PubMed ID: 35364254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural sesame oil is superior to pre-digested lipid formulations and purified triglycerides in promoting the intestinal lymphatic transport and systemic bioavailability of cannabidiol.
    Feng W; Qin C; Chu Y; Berton M; Lee JB; Zgair A; Bettonte S; Stocks MJ; Constantinescu CS; Barrett DA; Fischer PM; Gershkovich P
    Eur J Pharm Biopharm; 2021 May; 162():43-49. PubMed ID: 33677067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of lipophilic ester prodrugs of dolutegravir for intestinal lymphatic transport.
    Chu Y; Wong A; Chen H; Ji L; Qin C; Feng W; Stocks MJ; Gershkovich P
    Eur J Pharm Biopharm; 2023 Oct; 191():90-102. PubMed ID: 37634824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of tipranavir with long-chain triglyceride results in moderate intestinal lymph targeting but no efficient delivery to HIV-1 reservoir in mesenteric lymph nodes.
    Chu Y; Qin C; Feng W; Sheriston C; Jane Khor Y; Medrano-Padial C; Watson BE; Chan T; Ling B; Stocks MJ; Fischer PM; Gershkovich P
    Int J Pharm; 2021 Jun; 602():120621. PubMed ID: 33892057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies.
    Han S; Quach T; Hu L; Wahab A; Charman WN; Stella VJ; Trevaskis NL; Simpson JS; Porter CJ
    J Control Release; 2014 Mar; 177():1-10. PubMed ID: 24398334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing Linker Chain Length and Intestinal Stability Enhances Lymphatic Transport and Lymph Node Exposure of Triglyceride Mimetic Prodrugs of a Model Immunomodulator Mycophenolic Acid.
    Han S; Quach T; Hu L; Lim SF; Zheng D; Leong NJ; Sharma G; Bonner D; Simpson JS; Trevaskis NL; Porter CJH
    Mol Pharm; 2023 May; 20(5):2675-2685. PubMed ID: 36996486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of mycophenolic acid to the mesenteric lymph node using a triglyceride mimetic prodrug approach enhances gut-specific immunomodulation in mice.
    Kochappan R; Cao E; Han S; Hu L; Quach T; Senyschyn D; Ferreira VI; Lee G; Leong N; Sharma G; Lim SF; Nowell CJ; Chen Z; von Andrian UH; Bonner D; Mintern JD; Simpson JS; Trevaskis NL; Porter CJH
    J Control Release; 2021 Apr; 332():636-651. PubMed ID: 33609620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of lopinavir to HIV reservoirs in the mesenteric lymphatic system by lipophilic ester prodrug approach.
    Qin C; Chu Y; Feng W; Fromont C; He S; Ali J; Lee JB; Zgair A; Berton M; Bettonte S; Liu R; Yang L; Monmaturapoj T; Medrano-Padial C; Ugalde AAR; Vetrugno D; Ee SY; Sheriston C; Wu Y; Stocks MJ; Fischer PM; Gershkovich P
    J Control Release; 2021 Jan; 329():1077-1089. PubMed ID: 33091528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations.
    Franco V; Gershkovich P; Perucca E; Bialer M
    Clin Pharmacokinet; 2020 Dec; 59(12):1493-1500. PubMed ID: 32785853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral lipid-based formulations alter delivery of cannabidiol to different anatomical regions in the brain.
    Brookes A; Jewell A; Feng W; Bradshaw TD; Butler J; Gershkovich P
    Int J Pharm; 2023 Mar; 635():122651. PubMed ID: 36720447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vegetable oils composition affects the intestinal lymphatic transport and systemic bioavailability of co-administered lipophilic drug cannabidiol.
    Feng W; Qin C; Abdelrazig S; Bai Z; Raji M; Darwish R; Chu Y; Ji L; Gray DA; Stocks MJ; Constantinescu CS; Barrett DA; Fischer PM; Gershkovich P
    Int J Pharm; 2022 Aug; 624():121947. PubMed ID: 35753538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol.
    Kok LY; Bannigan P; Sanaee F; Evans JC; Dunne M; Regenold M; Ahmed L; Dubins D; Allen C
    Eur J Pharm Sci; 2022 Jan; 168():106058. PubMed ID: 34763088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
    Cherniakov I; Izgelov D; Domb AJ; Hoffman A
    Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers.
    Izgelov D; Davidson E; Barasch D; Regev A; Domb AJ; Hoffman A
    Eur J Pharm Biopharm; 2020 Sep; 154():108-115. PubMed ID: 32634571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport.
    Elz AS; Trevaskis NL; Porter CJH; Bowen JM; Prestidge CA
    J Control Release; 2022 Jan; 341():676-701. PubMed ID: 34896450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using the Absorption Cocktail Approach to Assess Differential Absorption Kinetics of Cannabidiol Administered in Lipid-Based Vehicles in Rats.
    Izgelov D; Regev A; Domb AJ; Hoffman A
    Mol Pharm; 2020 Jun; 17(6):1979-1986. PubMed ID: 32352800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Oil-in-Water Cannabidiol Emulsion for the Treatment of Rheumatoid Arthritis.
    Jelínek P; Roušarová J; Ryšánek P; Ježková M; Havlůjová T; Pozniak J; Kozlík P; Křížek T; Kučera T; Šíma M; Slanař O; Šoóš M
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):147-159. PubMed ID: 36342775
    [No Abstract]   [Full Text] [Related]  

  • 18. Mucoadhesive nanostructured lipid carriers as a cannabidiol nasal delivery system for the treatment of neuropathic pain.
    Matarazzo AP; Elisei LMS; Carvalho FC; Bonfílio R; Ruela ALM; Galdino G; Pereira GR
    Eur J Pharm Sci; 2021 Apr; 159():105698. PubMed ID: 33406408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration.
    Cherniakov I; Izgelov D; Barasch D; Davidson E; Domb AJ; Hoffman A
    J Control Release; 2017 Nov; 266():1-7. PubMed ID: 28890215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of medium chain and long chain triglycerides incorporated in self-nano emulsifying drug delivery systems on oral absorption of cannabinoids in rats.
    Izgelov D; Shmoeli E; Domb AJ; Hoffman A
    Int J Pharm; 2020 Apr; 580():119201. PubMed ID: 32147493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.